109 related articles for article (PubMed ID: 24890139)
1. Comparison of VEGF gene silencing efficiencies of chitosan and protamine complexes containing shRNA.
Erdem-Çakmak F; Özbaş-Turan S; Şalva E; Akbuğa J
Cell Biol Int; 2014 Nov; 38(11):1260-70. PubMed ID: 24890139
[TBL] [Abstract][Full Text] [Related]
2. The development of ternary nanoplexes for efficient small interfering RNA delivery.
Şalva E; Turan SÖ; Akbuğa J
Biol Pharm Bull; 2013; 36(12):1907-14. PubMed ID: 24432377
[TBL] [Abstract][Full Text] [Related]
3. Low-molecular weight chitosan/vascular endothelial growth factor short hairpin RNA for the treatment of hepatocellular carcinoma.
Huang Z; Dong L; Chen J; Gao F; Zhang Z; Chen J; Zhang J
Life Sci; 2012 Dec; 91(23-24):1207-15. PubMed ID: 23044224
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the therapeutic efficacy of codelivery of psiRNA-vascular endothelial growth factor and pIL-4 into chitosan nanoparticles in the breast tumor model.
Şalva E; Turan SO; Kabasakal L; Alan S; Özkan N; Eren F; Akbuğa J
J Pharm Sci; 2014 Mar; 103(3):785-95. PubMed ID: 24357345
[TBL] [Abstract][Full Text] [Related]
5. The enhancement of gene silencing efficiency with chitosan-coated liposome formulations of siRNAs targeting HIF-1α and VEGF.
Şalva E; Turan SÖ; Eren F; Akbuğa J
Int J Pharm; 2015 Jan; 478(1):147-154. PubMed ID: 25445537
[TBL] [Abstract][Full Text] [Related]
6. In vitro silencing effect of chitosan nanoplexes containing siRNA expressing vector targeting VEGF in breast cancer cell lines.
Salva E; Akbuğa J
Pharmazie; 2010 Dec; 65(12):896-902. PubMed ID: 21284259
[TBL] [Abstract][Full Text] [Related]
7. Chitosan/short hairpin RNA complexes for vascular endothelial growth factor suppression invasive breast carcinoma.
Salva E; Kabasakal L; Eren F; Cakalağaoğlu F; Ozkan N; Akbuğa J
Oligonucleotides; 2010 Aug; 20(4):183-90. PubMed ID: 20707740
[TBL] [Abstract][Full Text] [Related]
8. Quaternary complexes composed of plasmid DNA/protamine/fish sperm DNA/stearic acid grafted chitosan oligosaccharide micelles for gene delivery.
Du YZ; Lu P; Yuan H; Zhou JP; Hu FQ
Int J Biol Macromol; 2011 Jan; 48(1):153-9. PubMed ID: 21035503
[TBL] [Abstract][Full Text] [Related]
9. Nanocomposite-siRNA approach for down-regulation of VEGF and its receptor in myeloid leukemia cells.
Wang L; Zhang WJ; Xiu B; Ding Y; Li P; Ye WD; Zhu Q; Liang AB
Int J Biol Macromol; 2014 Feb; 63():49-55. PubMed ID: 24183807
[TBL] [Abstract][Full Text] [Related]
10. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
[TBL] [Abstract][Full Text] [Related]
11. Novel biotinylated chitosan-graft-polyethyleneimine copolymer as a targeted non-viral vector for anti-EGF receptor siRNA delivery in cancer cells.
Darvishi MH; Nomani A; Amini M; Shokrgozar MA; Dinarvand R
Int J Pharm; 2013 Nov; 456(2):408-16. PubMed ID: 24012865
[TBL] [Abstract][Full Text] [Related]
12. Ternary nanoparticles composed of cationic solid lipid nanoparticles, protamine, and DNA for gene delivery.
He SN; Li YL; Yan JJ; Zhang W; Du YZ; Yu HY; Hu FQ; Yuan H
Int J Nanomedicine; 2013; 8():2859-69. PubMed ID: 23990715
[TBL] [Abstract][Full Text] [Related]
13. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
[TBL] [Abstract][Full Text] [Related]
14. Chitosan/VEGF-sIRNA nanoparticle for gene silencing.
Yang Y; Liu X; Zhang D; Yu W; Lv G; Xie H; Zheng J; Ma X
J Control Release; 2011 Nov; 152 Suppl 1():e160-1. PubMed ID: 22195822
[No Abstract] [Full Text] [Related]
15. The suppression of lung tumorigenesis by aerosol-delivered folate-chitosan-graft-polyethylenimine/Akt1 shRNA complexes through the Akt signaling pathway.
Jiang HL; Xu CX; Kim YK; Arote R; Jere D; Lim HT; Cho MH; Cho CS
Biomaterials; 2009 Oct; 30(29):5844-52. PubMed ID: 19640582
[TBL] [Abstract][Full Text] [Related]
16. Ternary nanoparticles of anionic lipid nanoparticles/protamine/DNA for gene delivery.
Yuan H; Zhang W; Du YZ; Hu FQ
Int J Pharm; 2010 Jun; 392(1-2):224-31. PubMed ID: 20230883
[TBL] [Abstract][Full Text] [Related]
17. Nuclear localization signal peptides enhance transfection efficiency of chitosan/DNA complexes.
Opanasopit P; Rojanarata T; Apirakaramwong A; Ngawhirunpat T; Ruktanonchai U
Int J Pharm; 2009 Dec; 382(1-2):291-5. PubMed ID: 19716869
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cervical cancer cell growth in vitro and in vivo with dual shRNAs.
Gu W; Payne E; Sun S; Burgess M; McMillan NA
Cancer Gene Ther; 2011 Mar; 18(3):219-27. PubMed ID: 21102424
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of choroidal neovascularization by adenovirus-mediated delivery of short hairpin RNAs targeting VEGF as a potential therapy for AMD.
Cashman SM; Bowman L; Christofferson J; Kumar-Singh R
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3496-504. PubMed ID: 16877421
[TBL] [Abstract][Full Text] [Related]
20. Direct cytosolic siRNA delivery by reconstituted high density lipoprotein for target-specific therapy of tumor angiogenesis.
Ding Y; Wang Y; Zhou J; Gu X; Wang W; Liu C; Bao X; Wang C; Li Y; Zhang Q
Biomaterials; 2014 Aug; 35(25):7214-27. PubMed ID: 24875759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
